These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment options for acute decompensated heart failure. Southworth MR Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S7-15. PubMed ID: 12966901 [TBL] [Abstract][Full Text] [Related]
4. Congestive Heart Failure. Scott MC; Winters ME Emerg Med Clin North Am; 2015 Aug; 33(3):553-62. PubMed ID: 26226866 [TBL] [Abstract][Full Text] [Related]
5. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ; J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636 [TBL] [Abstract][Full Text] [Related]
6. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. Arnold LM; Crouch MA; Carroll NV; Oinonen MJ Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484 [TBL] [Abstract][Full Text] [Related]
7. What is evidence-based, what is new in medical therapy of acute heart failure? Grimm W Herz; 2006 Nov; 31(8):771-9. PubMed ID: 17149679 [TBL] [Abstract][Full Text] [Related]
8. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247 [TBL] [Abstract][Full Text] [Related]
9. Optimizing outcomes in the patient with acute decompensated heart failure. Mehra MR Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617 [TBL] [Abstract][Full Text] [Related]
10. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database. Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575 [TBL] [Abstract][Full Text] [Related]
12. Advances in chemical pharmacotherapy for managing acute decompensated heart failure. Yandrapalli S; Tariq S; Aronow WS Expert Opin Pharmacother; 2017 Apr; 18(5):471-485. PubMed ID: 28276970 [TBL] [Abstract][Full Text] [Related]
13. The benefits of early vasoactive therapy in the treatment of acute decompensated heart failure. Albert NM J Am Acad Nurse Pract; 2005 Oct; 17(10):403-10. PubMed ID: 16181262 [TBL] [Abstract][Full Text] [Related]
14. Acute decompensated heart failure: formulating an evidence-based approach to diagnosis and treatment (part II). Buccelletti F; Hermann L Mt Sinai J Med; 2006 Mar; 73(2):516-27. PubMed ID: 16568194 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure. Saltzberg MT Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915 [TBL] [Abstract][Full Text] [Related]
16. Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department. Emerman CL Rev Cardiovasc Med; 2003; 4 Suppl 7():S13-20. PubMed ID: 14668696 [TBL] [Abstract][Full Text] [Related]
17. Hospitalized patients with acute decompensated heart failure: recognition, risk stratification, and treatment review. Amin A J Hosp Med; 2008 Nov; 3(6 Suppl):S16-24. PubMed ID: 19084891 [TBL] [Abstract][Full Text] [Related]
18. Acute decompensated heart failure: evolving literature and implications for future practice. Cicci JD; Reed BN; McNeely EB; Oni-Orisan A; Patterson JH; Rodgers JE Pharmacotherapy; 2014; 34(4):373-88. PubMed ID: 24214219 [TBL] [Abstract][Full Text] [Related]
19. Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis. Wang XC; Zhu DM; Shan YX Am J Cardiovasc Drugs; 2015 Dec; 15(6):429-37. PubMed ID: 26123415 [TBL] [Abstract][Full Text] [Related]
20. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure. Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]